Skip to main content

Blood Bank

Continuous Quality Improvement

Continuous Quality Improvement (CQI) represents the evolutionary step beyond simple Quality Control (QC) and Quality Assurance (QA). While QC focuses on the product (e.g., “Did the reagent work today?”) and QA focuses on the process (e.g., “Did we follow the SOP?”), CQI focuses on the system. It is a structured, ongoing organizational process that actively seeks to identify problems, implement solutions, and measure the results to improve patient care, safety, and efficiency. In Blood Bank, where the margin for error is non-existent, CQI is the engine that drives the laboratory toward “Zero Defects.”

The PDCA Cycle: The Engine of Improvement

The fundamental framework for almost all CQI initiatives is the Plan-Do-Check-Act (PDCA) cycle, also known as the Deming Cycle. This iterative process ensures that changes are tested and validated before becoming permanent standard operating procedures

  • Plan: Identify a problem or an opportunity for improvement. Gather data to establish a baseline. Hypothesis: “If we change X, then Y will improve.”
    • Example: The Turnaround Time (TAT) for thawing plasma for the ER is consistently exceeding the 45-minute goal. The goal is to reduce it to 30 minutes
  • Do: Implement a corrective action or a process change on a small scale (pilot study)
    • Example: The lab rearranges the workflow so that the plasma thawer is closer to the issue window to reduce walking time, or implements a new “Rapid Thaw” device
  • Check (Study): Measure the results of the pilot study against the baseline data. Did the change actually work? Did it cause unintended negative side effects?
    • Example: Analyze the TAT for the next 50 plasma orders. Did the average drop? Did the error rate increase?
  • Act: If the change was successful, implement it permanently (update SOPs, train all staff). If it failed, cycle back to “Plan” and try a different solution
    • Example: The workflow change saved 5 minutes. The SOP is rewritten, and the layout change is made permanent

Quality Indicators (QIs) & Benchmarking

You cannot improve what you do not measure. A robust CQI program relies on Quality Indicators - specific, measurable metrics that reflect the health of the laboratory’s operations. These indicators are monitored monthly or quarterly

Pre-Analytical Indicators

  • Specimen Rejection Rate: The percentage of samples rejected due to hemolysis, clotting, or QNS (Quantity Not Sufficient)
  • Patient Identification Errors: The number of samples received with mislabeled or incomplete wristband information. This is the single most critical safety metric in Blood Bank
  • C/T Ratio (Crossmatch to Transfusion): A measure of ordering efficiency. A high ratio (e.g., > 2.5:1) indicates that physicians are ordering too much blood that isn’t being used, leading to inventory hoarding and increased workload

Analytical Indicators

  • Proficiency Testing Scores: Maintaining 100% on external surveys (CAP/API)
  • QC Failure Rates: The frequency with which daily reagent QC fails. High failure rates may indicate storage issues, instrument malfunction, or staff training deficits
  • Turnaround Time (TAT): The time from “Specimen In Lab” to “Result Verified.” This is broken down by priority (Stat vs. Routine)

Post-Analytical Indicators

  • Corrected Reports: The number of times a final result had to be amended after release
  • Wastage Rates: The percentage of Red Blood Cells or Platelets that expire before use. High wastage triggers an improvement project on inventory management (e.g., rotating stock to a trauma center)
  • Blood Utilization: Monitoring the number of single-unit transfusions vs. two-unit transfusions (promoting “Why give 2 when 1 will do?”)

Methodologies & Tools for Improvement

CQI utilizes specific tools borrowed from industrial engineering to analyze processes and identify the root causes of inefficiency

Lean (Removing Waste)

The goal of Lean is to eliminate non-value-added activities

  • The 7 Wastes: Transport, Inventory, Motion, Waiting, Overproduction, Over-processing, and Defects
  • Application: Creating a “Spaghetti Diagram” of Blood Bank to see how much laboratory scientists walk during a shift. Reorganizing the layout (moving the centrifuge next to the computer) reduces “Motion” waste, thereby improving TAT

Six Sigma (Reducing Variation)

The goal of Six Sigma is to reduce process variation and defects to near zero (3.4 defects per million opportunities)

  • DMAIC: Define, Measure, Analyze, Improve, Control
  • Application: Analyzing the variation in “Labeling Errors” from the ER. If Shift A has 1% errors and Shift B has 10% errors, Six Sigma seeks to identify the variable causing the difference (e.g., lack of barcode scanners on Shift B) and standardize the process

Root Cause Analysis (RCA)

When a significant error or “Near Miss” occurs, CQI demands a deep investigation to find the underlying cause, rather than blaming the individual

  • The “5 Whys”: A technique of asking “Why?” five times to drill down to the systemic issue
    • Problem: The wrong blood type was entered
    • Why? The laboratory scientist misread the tube
    • Why? The handwriting was illegible
    • Why? The label was handwritten, not printed
    • Why? The printer was out of labels
    • Root Cause: Lack of inventory control for printer supplies, NOT just “tech error.”
  • Fishbone Diagram (Ishikawa): A visual tool that categorizes causes into Equipment, People, Methods, Materials, and Environment to ensure no factor is overlooked

Failure Mode & Effects Analysis (FMEA)

While RCA is reactive (looking back at an error), FMEA is proactive (looking forward to prevent errors)

  • The Process: Before implementing a new test or workflow, the team brainstorms everything that could go wrong
  • Scoring: Each potential failure is scored on:
    1. Severity: How bad would it be? (1-10)
    2. Probability: How likely is it? (1-10)
    3. Detectability: Would we catch it before it reached the patient? (1-10)
  • Risk Priority Number (RPN): Severity × Probability × Detectability. The processes with the highest RPNs are fixed before the new test goes live

The Role of “Just Culture” in CQI

A continuous improvement program cannot function in a punitive environment. If staff are afraid of being fired for making a mistake, they will hide errors

  • Transparency: CQI relies on the voluntary reporting of “Near Misses” (Good Catches). A near miss (e.g., almost issuing the wrong unit but catching it at the last second) is free data. It highlights a weak spot in the system without the cost of patient harm
  • System Focus: The assumption of CQI is that 99% of employees come to work trying to do a good job. If they fail, it is usually because the system (protocols, environment, equipment) failed to support them

Regulatory Alignment

CQI is not optional; it is a requirement for accreditation

  • The “Quality System Essentials” (QSEs): Defined by AABB, these 10 areas (e.g., Organization, Facilities, Equipment, Process Control) must all be subject to continuous monitoring and improvement
  • FDA GMP: Good Manufacturing Practices require that when deviations occur, they are investigated, corrected, and that the correction is verified for effectiveness